Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
HTA in Essential Health Benefit Package Design
Health Technology Assessment in South Africa: Towards NHI
Unlocking the Potential of Cell and Gene Therapies: A Path to Affordable Heal...
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...
Transforming Healthcare: South Africa’s NHI Law Signed
Biosimilar Competition and Patient Out-of-Pocket Costs
Medical AI Future: Sustainable Reimbursement Strategies
Insights into Austria’s Pricing and Pharmaceutical Policy
Managed Access of Dostarlimab: For Endometrial Cancer
The Influence of AI on Risk Adjustment Models in Healthcare
The Cost-Effectiveness of GaitSmart Rehabilitation Programme
Economic Impact of Diabetes and High-Deductible Health Plans
« Previous
1
…
3
4
5
6
7
…
9
Next »